Related Experiment Video
Updated: Oct 14, 2025

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
Myocarditis Following mRNA COVID-19 Vaccine
Timothy Visclosky1, Nik Theyyunni, Nicole Klekowski
1From the Department of Emergency Medicine, University of Michigan, Ann Arbor, MI.
Abstract:
A growing number of adolescents are being diagnosed with acute myocarditis following mRNA COVID-19 vaccinations. This case describes an adolescent who presented to the emergency department with chest pain and tachycardia following the Pfizer-BioNTech COVID-19 vaccination. Point-of-care ultrasound was performed prior to the return of laboratory studies and revealed depressed left ventricular systolic function. Point-of-care ultrasound may be a tool used to rapidly diagnose or risk stratify patients with potential post-COVID-19 vaccine myocarditis.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Pericarditis I: Introduction
Pericarditis III: Medical Management

